National
In Portugal, more than 10 kg of cannabis have already been prescribed, but there are only 5 requests for ACM at Infarmed
Sales of cannabis for medicinal purposes in Portugal are still insignificant, but show signs of growth, according to the data revealed yesterday by Infarmed. With just one product (dry flower with 18% THC) and one drug (Sativex) in pharmacies, patients in Portugal say there is still a long way to go. There are only 5 requests for ACM (Marketing Authorization) awaiting evaluation by the Portuguese regulator, which does not meet the needs of patients, warns Paula Mota, from the Mothers for Cannabis Movement.
Cannabis for medicinal purposes in Portugal was legalized in 2018, however, it was only in 2021 that the first cannabis-based preparation was authorized in Portugal. The prescriptions for this preparation, under the legislation that provides for the ACM, have shown signs of growth, even though only one product is approved under this regime (Tilray Flor Seca THC 18).
In the first half of 2021, 126 packages of Tilray flowers were prescribed, a value that almost tripled in the second half, with 334 packages prescribed by doctors. From 2021 to June 2022, the product has already been prescribed 823 times, having almost tripled its homologous value in the first half of this year, to 326 prescriptions.
In total, in 2021, approximately 0 kg of cannabis were prescribed, a value that in the first half of 5 rose to 2022 kg and which can reach 10 kg of annual consumption at home. The therapy, which is not reimbursed by the state, although it can only be used as a last resort, has already cost patients more than 20 thousand euros.
Cannabis prescriptions in Portugal since 2019
Regulator is analyzing only 5 ACM requests
The Marketing Authorization (MCA) applications, advocated in the medical cannabis legislation, have established a set of mechanisms that allow companies to produce cannabis-based preparations and substances for medical purposes. These procedures aim to allow companies to place their products on the Portuguese market without having to resort to the Marketing Authorization (MA) procedure at European level.
Thirteen ACM requests have been made since 2019. However, only one has been approved and 5 are under analysis, with the other 7 having been invalidated, rejected or cancelled.
Table with information on requests for ACM for cannabis-based preparations and substances, since 2019. Report “Medical Cannabis – Evolution of activity” by Infarmed, IP.
Patients dissatisfied with slow process
To CannaReporter, Paula Mota, who heads the Mothers for Cannabis Movement, states that the product in question does not meet the needs of many patients, as it is “indicated for patients over 25 years of age and prohibited for those under 18. In addition, its prescription is only for some pathologies, namely chronic pain, nausea , spasticity, glaucoma, which leaves out epilepsy, for example”. The jurist, who has a 13-year-old daughter with refractory epilepsy, warns that there is no product with ACM “suitable for children and adults with epilepsy, this being the pathology where we have seen the most demand for this type of cannabis-based preparations”. On the other hand, the founder of the Movement warns that the “cost of the product is impractical for the majority of Portuguese patients”, stressing that “the fact that some doctors do not prescribe is due to the lack of analytical information regarding the content of the flower or even because they consider that vaping is not the best way to use this plant.”
Paula Mota recalls that “the products that Portuguese patients most need are preparations of oils based on the cannabis plant, with a predominance of CBD and lower THC levels, since most of these preparations are also used by children and by patients in whom vaporization is not advised.
CannaReporter sent several requests for additional statements that at the time of publication of the article had not yet been answered. Thus, the article will be updated as statements are made by the various players in the industry.
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
I am one of the directors of CannaReporter, which I founded together with Laura Ramos. I am from the unique Island of Madeira, where I currently reside. While I was in Lisbon at FCUL studying Physical Engineering, I became involved in the national hemp and cannabis scene and participated in several associations, some of which I am still a member of. I follow the global industry and especially legislative advances regarding the different uses of cannabis.
I can be contacted by email at joao.costa@cannareporter.eu
With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 2018st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “What does Lisbon say?” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura made the documentary “Pacientes” in XNUMX and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.
Brazil: São Paulo hosts 4th edition of Medical Cannabis Fair from May 22nd to 24th
From May 22 to 24, 2025, Expo Center Norte, in São Paulo, will host the 4th edition...
Jürgen Bickel: “I would like to see more respect for recreational users, because at least half of them are also medicinal users”
Jürgen Bickel, co-founder of Storz & Bickel, graduated in civil engineering and carpentry, but it was in technological innovation that he...
RED Horticulture Launches SCARLED™, a Cutting-Edge LED Lighting System for Precision Cannabis Cultivation
As the cannabis industry continues to evolve, growers have access to increasingly advanced tools...
SENSIHEMP wins excellence award at CSFW in Madrid with collection made 100% from hemp
SENSIHEMP, a Portuguese hemp fashion brand founded by Marta Vinhas, made a memorable presentation at the 9th edition of...
Netherlands: Fire consumes HempFlax hemp warehouse in Oude Pekela
A violent fire broke out on the night of May 12, 2025, in the hemp straw storage warehouse...
'Pepe' Mujica, former president of Uruguay and the first in the world to fully legalize cannabis, has died
José Mujica, former president of Uruguay, passed away today at the age of 89, leaving a unique legacy as the first head of state...
Hannah Deacon, a mother and medical cannabis campaigner in the UK, died on May 6, aged 45.
Notable mother and activist who played a key role in the legalisation of medicinal cannabis in the UK, Hannah Deacon,...
Have you tried psychedelics? You have until next Friday, May 16, to take part in a Global Survey, available in 18 languages
Michigan State University in the United States of America (USA) is conducting a global survey on psychedelics...
CannaPortugal returns to Lisbon on 16th and 17th May
On May 16th and 17th, 2025, the Instituto Superior de Agronomia, in Lisbon, will host CannaPortugal —...
European Congress of Psychiatry presents meta-analysis on the benefits of CBD in autism
A meta-analysis presented at the European Congress of Psychiatry in 2025 suggests that administration of CBD (cannabidiol) therapy may...
How many tons does Portugal produce? How much is prescribed in the countries where we export? where does all the production go?
Do the math!